Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 15, Pages 5406
Publisher
MDPI AG
Online
2020-07-30
DOI
10.3390/ijms21155406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the Prognostic Value of Positron Emission Tomography-Computed Tomography (PET-CT) at Diagnosis and Follow-up in Transplant-Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients Treated in the Phase 3 Cassiopeia Study: Results of the Cassiopet Companion Study
- (2020) Philippe Moreau et al. BLOOD
- Low hexokinase-2 expression-associated false-negative 18F-FDG PET/CT as a potential prognostic predictor in patients with multiple myeloma
- (2019) Yoshiaki Abe et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)
- (2019) Christina Messiou et al. RADIOLOGY
- Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
- (2019) Philippe Moreau et al. LANCET
- International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
- (2019) Jens Hillengass et al. LANCET ONCOLOGY
- Utilization of 18F-fluorodeoxyglucose – positron emission tomography (FDG-PET) to understand the mechanism of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors in vivo
- (2019) Sarah Mudd et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Fluorodeoxyglucose Uptake in Atheroma
- (2019) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT
- (2019) Qingqing Pan et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient
- (2018) Chao Wu et al. ACADEMIC RADIOLOGY
- Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy
- (2018) Constantin Lapa et al. BRITISH JOURNAL OF HAEMATOLOGY
- Multiple Myeloma Presenting as a Superscan on 68Ga-Pentixafor PET/CT
- (2018) Qingqing Pan et al. CLINICAL NUCLEAR MEDICINE
- Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma
- (2018) Faith E. Davies et al. HAEMATOLOGICA
- Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma
- (2018) Faith E. Davies et al. HAEMATOLOGICA
- Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma
- (2018) L. Rasche et al. LEUKEMIA
- Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction
- (2017) Arash Latifoltojar et al. EUROPEAN RADIOLOGY
- Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study
- (2017) Philippe Moreau et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of 18 F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
- (2017) Michele Cavo et al. LANCET ONCOLOGY
- Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
- (2017) L. Rasche et al. Nature Communications
- [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values
- (2017) Constantin Lapa et al. Theranostics
- Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma
- (2016) Julie C. Dutoit et al. EUROPEAN JOURNAL OF RADIOLOGY
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
- (2016) Shaji Kumar et al. LANCET ONCOLOGY
- Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging
- (2015) Ettore Squillaci et al. ACTA RADIOLOGICA
- Whole body diffusion weighted MRI - a new view of myeloma
- (2015) Christina Messiou et al. BRITISH JOURNAL OF HAEMATOLOGY
- PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma
- (2015) E. Zamagni et al. CLINICAL CANCER RESEARCH
- In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
- (2015) K. Philipp-Abbrederis et al. EMBO Molecular Medicine
- First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease
- (2015) K. Herrmann et al. JOURNAL OF NUCLEAR MEDICINE
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Assessment of Antiangiogenic Treatment Effects in Multiple Myeloma
- (2014) M. Merz et al. CLINICAL CANCER RESEARCH
- The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma
- (2014) Julie C. Dutoit et al. EUROPEAN RADIOLOGY
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Whole-Body Diffusion-weighted MR Imaging for Assessment of Treatment Response in Myeloma
- (2014) Sharon L. Giles et al. RADIOLOGY
- Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3
- (2013) S. Z. Usmani et al. BLOOD
- Bone metastases from prostate, breast and multiple myeloma: differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI
- (2012) T Pearce et al. BRITISH JOURNAL OF RADIOLOGY
- The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM)
- (2012) Cristina Nanni et al. CLINICAL NUCLEAR MEDICINE
- Whole-Body Diffusion-Weighted MRI With Apparent Diffusion Coefficient Mapping for Early Response Monitoring in Multiple Myeloma: Preliminary Results
- (2011) Marius Horger et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
- (2011) E. Zamagni et al. BLOOD
- Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility
- (2011) C. Messiou et al. EUROPEAN RADIOLOGY
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Induction of angiogenesis by normal and malignant plasma cells
- (2009) D. Hose et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started